BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6206840)

  • 1. Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice.
    Kirchner H; Chmielarczyk W; Storch E; Schindler L
    Behring Inst Mitt; 1984 May; (74):183-8. PubMed ID: 6206840
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attempts to correlate interferon induction and activation of natural killer cells by Corynebacterium parvum.
    Chmielarczyk W; Kirchner H; Ernst R; Storch E
    Immunobiology; 1985 May; 169(4):403-11. PubMed ID: 2408996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of endogenous interferon in natural and induced antiviral resistance.
    Kirchner H; Zawatzky R; Storch E; Domke I; Chmielarczyk W
    Antiviral Res; 1985; Suppl 1():155-9. PubMed ID: 2417549
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of mice against mouse hepatitis virus by Corynebacterium parvum.
    Schindler L; Streissle G; Kirchner H
    Infect Immun; 1981 Jun; 32(3):1128-31. PubMed ID: 6166566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 1 replication and IL-1 beta gene expression in mouse peritoneal macrophages activated in vivo by an attenuated Salmonella typhimurium vaccine or Corynebacterium parvum.
    Wu L; Morahan PS; Hendrzak JA; Eisenstein TK
    Microb Pathog; 1994 Jun; 16(6):387-99. PubMed ID: 7830526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural killer cells in host defense against cancer metastasis.
    Hanna N
    Symp Fundam Cancer Res; 1983; 36():309-19. PubMed ID: 6382510
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon inducibility in mice treated with Corynebacterium parvum.
    Storch E; Kirchner H
    Antiviral Res; 1985 Apr; 5(2):117-23. PubMed ID: 2409917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects on the lymphreticular system and inhibition of liver microsomaal cytochrome P-450 in mice administered Priopionibacterium acnes (Corynebacterium parvum) bacterin].
    Ocenásková J; Mára M; Bednár M; Veselská M; Adamcová D
    Cesk Epidemiol Mikrobiol Imunol; 1985 Mar; 34(2):100-6. PubMed ID: 3157461
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.
    Hirt HM; Schwenteck M; Becker H; Kirchner H
    Clin Exp Immunol; 1978 Jun; 32(3):471-6. PubMed ID: 688696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L; McGowan P; Ashe S; Johnston JV; Hellström I; Hellström KE
    Cancer Res; 1994 Oct; 54(20):5420-3. PubMed ID: 7522958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Corynebacterium parvum on liver proliferation and regeneration.
    Fisher B; Gebhardt MC; Saffer EA; Fisher ER
    Cancer Res; 1979 Apr; 39(4):1361-8. PubMed ID: 421219
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental nonspecific immunostimulation by the Propionibacterium acnes vaccine.
    Koukalová D; Kod'ousek R; Hájek V; Kolár M
    Acta Univ Palacki Olomuc Fac Med; 1992; 133():19-23. PubMed ID: 1344592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
    Hanna N
    Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: effects of immunomodulators in beige mice and 89Sr-treated mice.
    Morahan PS; Coleman PH; Morse SS; Volkman A
    Infect Immun; 1982 Sep; 37(3):1079-85. PubMed ID: 6290389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of natural killer cell activity in spleens of infant, aged, and low responder strain mice by Corynebacterium parvum.
    Gallagher MT; Nasrallah AG; Datta SK; Priest EL; Trentin JJ
    Exp Hematol; 1981 Feb; 9(2):149-55. PubMed ID: 7238649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cancer with corynebacterium parvum.
    Halpern B
    Ann Allergy; 1978 Mar; 40(3):155-7. PubMed ID: 637374
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
    Kanda T; Yokoyama T; Suzuki T; Murata K
    Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host defences in mice against infections with herpes simplex virus.
    Mogensen SC
    Microbiol Sci; 1984 Aug; 1(5):127-30. PubMed ID: 6086079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.